Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro
暂无分享,去创建一个
[1] P. Dhawan,et al. C/EBPα and the Vitamin D Receptor Cooperate in the Regulation of Cathelicidin in Lung Epithelial Cells , 2015, Journal of cellular physiology.
[2] K. Iwatsuki,et al. Cathelicidin antimicrobial peptide LL‐37 augments interferon‐β expression and antiviral activity induced by double‐stranded RNA in keratinocytes , 2014, The British journal of dermatology.
[3] M. Loeb,et al. Vitamin D3 and gargling for the prevention of upper respiratory tract infections: a randomized controlled trial , 2014, BMC Infectious Diseases.
[4] J. Gern,et al. Effects of Vitamin D on Airway Epithelial Cell Morphology and Rhinovirus Replication , 2014, PloS one.
[5] D. Davidson,et al. Antiviral potential of cathelicidins. , 2014, Future microbiology.
[6] Derek Macmillan,et al. The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus , 2013, PloS one.
[7] M. Blettner,et al. Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency , 2013, Respiratory Research.
[8] Divyendu Singh,et al. The Human Antimicrobial Peptide LL-37, but Not the Mouse Ortholog, mCRAMP, Can Stimulate Signaling by Poly(I:C) through a FPRL1-dependent Pathway* , 2013, The Journal of Biological Chemistry.
[9] K. Hartshorn,et al. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. , 2013, The Journal of general virology.
[10] C. Camargo,et al. Randomized Trial of Vitamin D Supplementation and Risk of Acute Respiratory Infection in Mongolia , 2012, Pediatrics.
[11] W. Banya,et al. Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. , 2011, American journal of respiratory and critical care medicine.
[12] R. Koren,et al. Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes , 2011, Hepatology.
[13] K. Bhardwaj,et al. LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs , 2011, PloS one.
[14] S. Kato,et al. The Vitamin D3 1alpha-Hydroxylase Gene and Its Regulation by Active Vitamin D3 , 2011, Bioscience, biotechnology, and biochemistry.
[15] J. Oxford,et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. , 2010, American journal of respiratory and critical care medicine.
[16] R. Peebles,et al. Respiratory syncytial virus infections in the adult asthmatic--mechanisms of host susceptibility and viral subversion. , 2010, Immunology and allergy clinics of North America.
[17] J. Brehm,et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. , 2010, The Journal of allergy and clinical immunology.
[18] P. DePetrillo,et al. Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults , 2010, PloS one.
[19] M. Urashima,et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. , 2010, The American journal of clinical nutrition.
[20] S. Johnston,et al. Azithromycin induces anti-viral responses in bronchial epithelial cells , 2010, European Respiratory Journal.
[21] G. Hunninghake,et al. Vitamin D Decreases Respiratory Syncytial Virus Induction of NF-κB–Linked Chemokines and Cytokines in Airway Epithelium While Maintaining the Antiviral State , 2009, The Journal of Immunology.
[22] K. Poehling,et al. The burden of respiratory syncytial virus infection in young children. , 2009, The New England journal of medicine.
[23] C. Camargo,et al. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.
[24] G. Hunninghake,et al. Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host Defense1 , 2008, The Journal of Immunology.
[25] P. Dhawan,et al. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[26] J. Adams,et al. Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.
[27] S. Johnston,et al. Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. , 2006, The Journal of infectious diseases.
[28] S. Johnston,et al. Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. , 2006, American journal of respiratory cell and molecular biology.
[29] S. Johnston,et al. Toll-Like Receptor 3 Is Induced by and Mediates Antiviral Activity against Rhinovirus Infection of Human Bronchial Epithelial Cells , 2005, Journal of Virology.
[30] E. Walsh,et al. Respiratory syncytial virus infection in elderly and high-risk adults. , 2005, The New England journal of medicine.
[31] S. Holgate,et al. Rhinovirus infection up‐regulates eotaxin and eotaxin‐2 expression in bronchial epithelial cells , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[32] R. Bals,et al. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] Stephen T Holgate,et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.
[34] R I Lehrer,et al. Direct inactivation of viruses by human granulocyte defensins , 1986, Journal of virology.